D

Dhg Pharmaceutical Joint-Stock Co
VN:DHG

Watchlist Manager
Dhg Pharmaceutical Joint-Stock Co
VN:DHG
Watchlist
Price: 102 700 VND 0.1% Market Closed
Market Cap: 13.4T VND
Have any thoughts about
Dhg Pharmaceutical Joint-Stock Co?
Write Note

Intrinsic Value

The intrinsic value of one DHG stock under the Base Case scenario is 101 673.06 VND. Compared to the current market price of 102 700 VND, Dhg Pharmaceutical Joint-Stock Co is Overvalued by 1%.

DHG Intrinsic Value
101 673.06 VND
Overvaluation 1%
Intrinsic Value
Price
D
Worst Case
Base Case
Best Case

Valuation Backtest
Dhg Pharmaceutical Joint-Stock Co

Backtest Intrinsic Value
Dive into the past to invest in the future

Uncover deeper insights with the Valuation Backtest. Learn how current stock valuations stack up against historical averages to gauge true investment potential.

Start backtest now and learn if your stock is truly undervalued or overvalued!

Run Backtest
Backtest Conclusion
Very Attractive
Current Valuation
+45%
Avg Valuation
-12%
Worst Valuation
-49%
Best Valuation
+45%

Stock is trading at its lowest valuation over the past 5 years.

Backtest Example
Register to View Results
Register to View Results

To access the results of this valuation backtest, please register an account with us. Registration is quick and gives you instant access to insights on 3 stocks per week for free.

Backtest Unavailable

The backtest for DHG cannot be conducted due to limitations such as insufficient data or other constraints. Please select a different stock or adjust your settings.

Backtest In Progress...
Backtest In Progress...
How do you feel about DHG?
Bearish
Neutral
Bullish
Discover Undervalued Stocks
Pharmaceuticals Industry

Fundamental Analysis

Risks & Rewards

 

 

 

 

View All Risks & Rewards
Company Quality
No Indicators Selected
Select Indicators

Select up to 3 indicators:

Insider Trading
0-3
Months
0-6
Months
0-12
Months
0-36
Months
No Periods Selected
Select Periods

Select up to 2 periods:

Notes
AI Assistant
AI Assistant
Ask me anything about Dhg Pharmaceutical Joint-Stock Co

Provide an overview of the primary business activities
of Dhg Pharmaceutical Joint-Stock Co.

What unique competitive advantages
does Dhg Pharmaceutical Joint-Stock Co hold over its rivals?

What risks and challenges
does Dhg Pharmaceutical Joint-Stock Co face in the near future?

Is it considered overvalued or undervalued
based on the latest financial data?

Show all valuation multiples
for Dhg Pharmaceutical Joint-Stock Co.

Provide P/S
for Dhg Pharmaceutical Joint-Stock Co.

Provide P/E
for Dhg Pharmaceutical Joint-Stock Co.

Provide P/OCF
for Dhg Pharmaceutical Joint-Stock Co.

Provide P/FCFE
for Dhg Pharmaceutical Joint-Stock Co.

Provide P/B
for Dhg Pharmaceutical Joint-Stock Co.

Provide EV/S
for Dhg Pharmaceutical Joint-Stock Co.

Provide EV/GP
for Dhg Pharmaceutical Joint-Stock Co.

Provide EV/EBITDA
for Dhg Pharmaceutical Joint-Stock Co.

Provide EV/EBIT
for Dhg Pharmaceutical Joint-Stock Co.

Provide EV/OCF
for Dhg Pharmaceutical Joint-Stock Co.

Provide EV/FCFF
for Dhg Pharmaceutical Joint-Stock Co.

Provide EV/IC
for Dhg Pharmaceutical Joint-Stock Co.

Show me price targets
for Dhg Pharmaceutical Joint-Stock Co made by professional analysts.

What are the Revenue projections
for Dhg Pharmaceutical Joint-Stock Co?

How accurate were the past Revenue estimates
for Dhg Pharmaceutical Joint-Stock Co?

What are the Net Income projections
for Dhg Pharmaceutical Joint-Stock Co?

How accurate were the past Net Income estimates
for Dhg Pharmaceutical Joint-Stock Co?

What are the EPS projections
for Dhg Pharmaceutical Joint-Stock Co?

How accurate were the past EPS estimates
for Dhg Pharmaceutical Joint-Stock Co?

What are the EBIT projections
for Dhg Pharmaceutical Joint-Stock Co?

How accurate were the past EBIT estimates
for Dhg Pharmaceutical Joint-Stock Co?

Compare the revenue forecasts
for Dhg Pharmaceutical Joint-Stock Co with those of its competitors based on recent analyst estimates.

Compare the intrinsic valuations
of Dhg Pharmaceutical Joint-Stock Co and its key competitors using the latest financial data.

Compare historical revenue growth rates
of Dhg Pharmaceutical Joint-Stock Co against its competitors.

Analyze the profit margins
(gross, operating, and net) of Dhg Pharmaceutical Joint-Stock Co compared to its peers.

Compare the P/E ratios
of Dhg Pharmaceutical Joint-Stock Co against its peers.

Discuss the investment returns and shareholder value creation
comparing Dhg Pharmaceutical Joint-Stock Co with its peers.

Analyze the financial leverage
of Dhg Pharmaceutical Joint-Stock Co compared to its main competitors.

Show all profitability ratios
for Dhg Pharmaceutical Joint-Stock Co.

Provide ROE
for Dhg Pharmaceutical Joint-Stock Co.

Provide ROA
for Dhg Pharmaceutical Joint-Stock Co.

Provide ROIC
for Dhg Pharmaceutical Joint-Stock Co.

Provide ROCE
for Dhg Pharmaceutical Joint-Stock Co.

Provide Gross Margin
for Dhg Pharmaceutical Joint-Stock Co.

Provide Operating Margin
for Dhg Pharmaceutical Joint-Stock Co.

Provide Net Margin
for Dhg Pharmaceutical Joint-Stock Co.

Provide FCF Margin
for Dhg Pharmaceutical Joint-Stock Co.

Show all solvency ratios
for Dhg Pharmaceutical Joint-Stock Co.

Provide D/E Ratio
for Dhg Pharmaceutical Joint-Stock Co.

Provide D/A Ratio
for Dhg Pharmaceutical Joint-Stock Co.

Provide Interest Coverage Ratio
for Dhg Pharmaceutical Joint-Stock Co.

Provide Altman Z-Score Ratio
for Dhg Pharmaceutical Joint-Stock Co.

Provide Quick Ratio
for Dhg Pharmaceutical Joint-Stock Co.

Provide Current Ratio
for Dhg Pharmaceutical Joint-Stock Co.

Provide Cash Ratio
for Dhg Pharmaceutical Joint-Stock Co.

What is the historical Revenue growth
over the last 5 years for Dhg Pharmaceutical Joint-Stock Co?

What is the historical Net Income growth
over the last 5 years for Dhg Pharmaceutical Joint-Stock Co?

What is the current Free Cash Flow
of Dhg Pharmaceutical Joint-Stock Co?

Discuss the annual earnings per share (EPS)
trend over the past five years for Dhg Pharmaceutical Joint-Stock Co.

Financials
Annual
Quarterly
TTM
Annual
Quarterly
TTM

Balance Sheet Decomposition
Dhg Pharmaceutical Joint-Stock Co

Current Assets 4.7T
Cash & Short-Term Investments 2.7T
Receivables 532.6B
Other Current Assets 1.5T
Non-Current Assets 1.4T
Long-Term Investments 35.6B
PP&E 1.2T
Intangibles 180B
Other Non-Current Assets 78.4B
Current Liabilities 1.8T
Accounts Payable 224.4B
Accrued Liabilities 232.7B
Short-Term Debt 810.9B
Other Current Liabilities 564.2B
Non-Current Liabilities 69.5B
Other Non-Current Liabilities 69.5B
Efficiency

Earnings Waterfall
Dhg Pharmaceutical Joint-Stock Co

Revenue
5T VND
Cost of Revenue
-2.8T VND
Gross Profit
2.2T VND
Operating Expenses
-1.4T VND
Operating Income
824B VND
Other Expenses
-10.2B VND
Net Income
813.8B VND

Free Cash Flow Analysis
Dhg Pharmaceutical Joint-Stock Co

Last Value
3-Years Average
FCF Margin
Conversion Rate
Fundamental Scores

DHG Profitability Score
Profitability Due Diligence

Dhg Pharmaceutical Joint-Stock Co's profitability score is 63/100. The higher the profitability score, the more profitable the company is.

Exceptional 3-Year Average ROIC
Positive Gross Profit
Positive 3-Year Average ROE
Positive Free Cash Flow
63/100
Profitability
Score

Dhg Pharmaceutical Joint-Stock Co's profitability score is 63/100. The higher the profitability score, the more profitable the company is.

DHG Solvency Score
Solvency Due Diligence

Dhg Pharmaceutical Joint-Stock Co's solvency score is 92/100. The higher the solvency score, the more solvent the company is.

High Interest Coverage
High Altman Z-Score
Negative Net Debt
Low D/E
92/100
Solvency
Score

Dhg Pharmaceutical Joint-Stock Co's solvency score is 92/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

DHG Price Targets Summary
Dhg Pharmaceutical Joint-Stock Co

Wall Street analysts forecast DHG stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for DHG is 108 320.43 VND with a low forecast of 96 758 VND and a high forecast of 122 422.65 VND.

Lowest
Price Target
96 758 VND
6% Downside
Average
Price Target
108 320.43 VND
5% Upside
Highest
Price Target
122 422.65 VND
19% Upside
View Analyst Estimates
View Analyst Estimates
Want to learn more about Wall St estimates for DHG?

Click here to dive deeper.

Dividends

Dividend Yield
Lowest
Average
Highest
Dividend Per Share
N/A
Growth 3Y
Growth 5Y
Growth 10Y
Dividend Safety Score
Very
Unsafe
Unsafe
Safe
Very
Safe
0
25
50
75
100
Shareholder Yield

Current shareholder yield for DHG is .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
Dividend Yield
Lowest
Average
Highest
Buyback Yield
Lowest
Average
Highest
Debt Paydown Yield
Lowest
Average
Highest

Profile

Dhg Pharmaceutical Joint-Stock Co

Country

Vietnam

Industry

Pharmaceuticals

Market Cap

13.4T VND

Dividend Yield

7.3%

Description

DHG Pharmaceutical JSC engages in the production, sale, and trade of pharmaceutical products. The company is headquartered in Can Tho, Can Tho and currently employs 2,770 full-time employees. The company went IPO on 2006-12-21. The firm manufactures and markets pharmaceutical products, vitamins, supplements and cosmetics. Via its subsidiaries, the Company is also involved in packaging printing, herb cultivation, medicinal supplies trading, as well as domestic travel tour and medical clinic operation.

Contact

CAN THO
Can Tho
288 Bis Nguyen Van Cu, P. An Hoa, Q. Ninh Kieu
+842923891433
www.dhgpharma.com.vn

IPO

2006-12-21

Employees

2 770

Officers

General Director, Legal Representative & Director
Mr. Toshiyuki Ishii
Chief Accountant
Mr. Huan Buu Ho
Technology Director
Mr. Y. Vo Van Kim
Board of Director Secretary
Ms. Loan Kim Duong

See Also

Discover More
What is the Intrinsic Value of one DHG stock?

The intrinsic value of one DHG stock under the Base Case scenario is 101 673.06 VND.

Is DHG stock undervalued or overvalued?

Compared to the current market price of 102 700 VND, Dhg Pharmaceutical Joint-Stock Co is Overvalued by 1%.

Back to Top